Journal profile · ENDOCRINOLOGY & METABOLISM
International Journal of Diabetes in Developing Countries
ISSN 0973-3930 · eISSN 1998-3832 · Springer India · INDIA · Quarterly · Founded 2011
International Journal of Diabetes in Developing Countries: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.78; hybrid open access; APC about USD 3,890; median 143 days to acceptance (103 articles, last 24 months); community-reported acceptance: about 50%; 169 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Journal of Diabetes in Developing Countries is published by Springer India and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Research and Diabetes Management and Education, together about 34.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
International Journal of Diabetes in Developing Countries is the official peer-reviewed journal of Research Society for the Study of Diabetes in India (RSSDI)commanding a membership of over 8700 at present with more than 8500 print copies being published per issue apart from being hosted online by publishers Springer Nature. The primary goal of the journal is to serve as an important, all-encompassing resource and reference guide for its readers consisting of clinicians, research workers, paramedical personnel, nutritionists and health care personnel working in the field of diabetes, mainly from the developing world. The journal receives original research articles, systematic reviews with meta-analysis, consensus and guidelines, short articles focusing on the epidemiology, etiopathogenesis, psychosocial aspects, complications and emergencies, community health, new technology/quality improvement strategies, novel therapeutic modalities, pharmacoeconomics, management as part of its clinical and basic science research spectrum and scope in the arena of diabetes. DESCRIPTION: The journal founded by Prof. Hemraj Chandalia and Late Prof. MMS Ahuja is in its 41st year of publication with quarterly issues and a RSSDI conference abstract supplement published annually. Submissions to the journal are received from across developing countries such as India , Bangladesh, Pakistan, West Africa, Iran, Turkey. The journal also receives submissions from Japan, Brazil, Nepal, Sri Lanka and China. The reviewers are selected from both developed and developing countries using a wide range of reviewer selection tools to ensure a more holistic and in depth approach to the peer review process. The preproduction and production workflow of the journal is managed through the Editorial Manager software that is customized as per the editorial requirements of the journal, wherever possible. The journal is funded by the RSSDI Society.
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Rajeev ChawlaPublisher website
Editorial board by country: none in mainland China; most named India 89, United States 6, Egypt 1, United Arab Emirates 1, Bangladesh 1 (99 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine13.7%
- Diabetes Management and ResearchMedicine13.2%
- Diabetes Management and EducationMedicine7.8%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology7.2%
- Diabetes Treatment and ManagementMedicine6.7%
- Pancreatic function and diabetesMedicine4.4%
- Liver Disease Diagnosis and TreatmentMedicine4%
- Diabetic Foot Ulcer Assessment and ManagementMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASCAB AbstractsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.78LetPub ·
- Impact factor (publisher) 2025
- 0.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.9Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- SJR 2026-06
- 0.3LetPub ·
- SNIP 2026-06
- 0.37LetPub ·
- h-index
- 22LetPub ·
- h-index
- 44OpenAlex ·
- i10-index
- 318OpenAlex ·
- 2-year mean citedness
- 0.88OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 7.85%LetPub ·
Volume
- Articles per year
- 148LetPub ·
- Downloads per year (publisher) 2025
- 170,100Publisher website ·
Articles by year OpenAlex count · 1,893 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 128 | 6 | 23 |
| 2025 | 169 | 19 | 104 |
| 2024 | 130 | 18 | 247 |
| 2023 | 141 | 30 | 349 |
| 2022 | 128 | 34 | 545 |
| 2021 | 138 | 23 | 591 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
143 daysMedian, submission to acceptance · P25–P75 88 days – 262 days
- Acceptance to online
- median 23 days (103 articles)
- Submission to online
- median 170 days
- Sample
- 103 articles with submission and acceptance dates (318 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to first decision
- 17 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,890 / EUR 2,890 / GBP 2,490 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
Article types accepted7
- case reportORIGINAL ARTICLE: These include randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, cost effectivenes…Length not stated
- letterORIGINAL ARTICLE: These include randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, cost effectivenes…Length not stated
- meta-analysisORIGINAL ARTICLE: These include randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, cost effectivenes…Length not stated
- narrative reviewORIGINAL ARTICLE: These include randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, cost effectivenes…Length not stated
- original articleORIGINAL ARTICLE: These include randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, cost effectivenes…Length not stated
- review articleORIGINAL ARTICLE: These include randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, cost effectivenes…Length not stated
- surveyORIGINAL ARTICLE: These include randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, cost effectivenes…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship Criteria
Authorship credit should be based only on substantial contributions 1. to conception and design or acquisition of data or analysis and interpretation of data; 2. drafting the article or revising it critically for important intellectual content; and 3. final approval of the version to be published. Conditions 1, 2, and 3 must all be met. Participation solely in the acquisition of funding or the col…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability
Data transparency policy Model summary
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards.
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in International Journal of Diabetes in Developing Countries, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer India
- Country or region
- INDIA
- Language
- English
- Frequency
- Quarterly
- Founded
- 2011
- ISSN
- 0973-3930
- Electronic ISSN
- 1998-3832
- Latest issue on the website
- Volume 46, Issue 3 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about International Journal of Diabetes in Developing Countries
What CAS zone is International Journal of Diabetes in Developing Countries in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Diabetes in Developing Countries is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Diabetes in Developing Countries?
The latest impact factor listed by LetPub is 0.78; CiteScore 1.8, h-index 44.
How long does peer review take at International Journal of Diabetes in Developing Countries?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 143 days (interquartile range 88–262 days); authors report an average review time of about 6 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of International Journal of Diabetes in Developing Countries?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of International Journal of Diabetes in Developing Countries based?
Of the 99 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (89), United States (6) and Egypt (1). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Diabetes in Developing Countries?
According to LetPub and DOAJ records, International Journal of Diabetes in Developing Countries is indexed in SCIE and Scopus. The journal's website also lists Embase, CAS and CAB Abstracts; that list has not been checked against each database.
Is International Journal of Diabetes in Developing Countries open access, and what is the APC?
International Journal of Diabetes in Developing Countries is a hybrid journal. For open-access publication: APC about USD 3,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .